Adnexal masses in pregnancy.
With the increased use and quality of ultrasound in pregnancy, adenxal masses are being encountered with greater frequency. Fortunately, most of such masses are benign and resolve on their own. However, complications such as ovarian torsion can occur. In addition, a malignancy can be present in a small minority of cases. In this article, we review the available literature on this subject to help guide the clinician in the diagnosis and management of adnexal masses in pregnancy.
Schwartz
Nadav
N
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. schwartn@obgyn.upenn.edu
Timor-Tritsch
Ilan E
IE
Wang
Eileen
E
D000291:Adnexal Diseases / Q000175:diagnosis* / Q000601:surgery*; D014408:Biomarkers, Tumor / Q000097:blood; D018394:CA-125 Antigen / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D003560:Cysts / Q000175:diagnosis / Q000601:surgery; D005260:Female; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000175:diagnosis / Q000601:surgery; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis* / Q000517:prevention & control / Q000601:surgery*; D011256:Pregnancy Outcome; D011374:Progesterone / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use; D014102:Torsion Abnormality / Q000175:diagnosis / Q000601:surgery; D018608:Ultrasonography, Doppler; D000509:alpha-Fetoproteins / Q000032:analysis
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D006063:Chorionic Gonadotropin; D011372:Progestins; D000509:alpha-Fetoproteins; D011374:Progesterone